FDA Inspection 1215345 — GlaxoSmithKline Biologicals SA
The FDA completed an inspection of GlaxoSmithKline Biologicals SA on Jun 23, 2023 in Rixensart. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 23, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Rixensart (Belgium)